Info-Tech Research Group Names Laserfiche a Leader in Enterprise Content Management – Enterprise Report
Laserfiche has been named a Champion for the enterprise category in the Enterprise Content Management Emotional Footprint 2025 Report by Info-Tech Research Group. Laserfiche — the leading enterprise platform that helps organizations manage their most critical content and workflows — was recognized based on reviews provided by end users. Laserfiche was named a Champion for having great customer relationships and a product that delivers a strong return on investment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610817168/en/
Laserfiche Champions at Empower 2025
“We are excited to be recognized as a 2025 Emotional Footprint Champion,” said Thomas Phelps, CIO and SVP of corporate strategy at Laserfiche. “Out of 416 customers who completed Info-Tech surveys this year, 99% shared they plan to renew.
“Our customers have recognized us not only for delivering innovative, high-impact solutions, but for building trust and providing an exceptional customer experience.”
Info-Tech Research Group’s Emotional Footprint report quantifies the end-user experience and value provided by a specific product and the relationship end users have with the provider. Laserfiche received a Net Emotional Footprint of 94 and a CX score of 9.3. It was the highest scoring vendor in the categories of Integrity, Fairness, Security and Unique Features.
The Emotional Footprint reports from Info-Tech Research Group are based on authentic user-review data. Laserfiche reviews include the following:
- “You will be amazed to discover how Laserfiche is one of the best products in its category and supported by real professionals.” – C-Level in Construction
- “Laserfiche offers excellent ways to onboard new clients and access to company documents.” – C-Level in Finance
- “My favorite aspect of Laserfiche is its seamless integration of document management with workflow automation, allowing for greater efficiency and collaboration across teams. The ability to automate processes while maintaining compliance and security is particularly impressive.” – IT Manager in Finance
- “You won't regret buying this product. The business value it has given our business has enabled us to automate a lot of processes internally and the clients love how things are streamlined. Do your homework on what this solution can enable in your business and the more you can think outside the box, the more you will see that Laserfiche can do almost anything that you want it to do.” – IT Manager in Education
Laserfiche empowers organizations to automate processes, enhance collaboration and support compliance. The company recently announced new AI features to further boost productivity and unlock business value. These included Smart Fields for intelligent data capture and Smart Chat for instant insights from documents using natural language.
“Our organizational mission is to provide science-based stewardship for the health and prosperity of all North Carolinians,” said Miriam Patrocinio, chief data officer at the North Carolina Department of Environmental Quality. “Laserfiche’s ease of use, robust forms and workflow automation, and leading AI-driven features enable us to achieve that mission by enhancing the efficiency and scalability of our work, allowing us to stay focused on serving citizens.”
To learn more:
- Read more Laserfiche reviews
- Visit the Laserfiche website
About Info-Tech Research Group
Info-Tech Research Group is one of the world’s leading research and advisory firms, proudly serving over 30,000 IT and HR professionals. The company produces unbiased, highly relevant research and provides advisory services to help leaders make strategic, timely, and well-informed decisions. For nearly 30 years, Info-Tech has partnered closely with teams to provide them with everything they need, from actionable tools to analyst guidance, ensuring they deliver measurable results for their organizations. To learn more about Info-Tech’s divisions, visit SoftwareReviews for software buying insights or McLean & Company for HR research and advisory services.
About Laserfiche
Laserfiche is a leading enterprise platform that helps organizations digitally transform operations and manage their content with AI-powered solutions. Through scalable workflows, customizable forms, no-code templates and AI-enabled capabilities, the Laserfiche® document management platform accelerates how business gets done. Trusted by organizations of all sizes — from startups to Fortune 500 enterprises — Laserfiche empowers teams to boost productivity, foster collaboration, and deliver a superior customer experience at scale. Headquartered in Long Beach, California, Laserfiche operates globally, with offices across North America, Europe, and Asia.
Connect with Laserfiche:
Laserfiche Blog | X | LinkedIn | Facebook | YouTube
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610817168/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 00:45:00 CEST | Press release
POD1UM-303/InterAACT 2 is the first and largest global Phase 3 trial evaluating a PD-1 inhibitor in combination with chemotherapy for the treatment of patients with advanced SCAC not previously treated with systemic chemotherapy The trial met its primary endpoint; treatment with retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) resulted in clinically meaningful improvements in progression-free survival and overall survival In May 2025, the U.S. Food and Drug Administration (FDA) approved Zynyz® (retifanlimab-dlwr) in combination with carboplatin and paclitaxel and as a single agent for the treatment of advanced SCAC; submissions to other global regulatory agencies are also under review Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-base
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 21:30:00 CEST | Press release
Progress in natural refrigerants, water efficiency and circular economy underscores Güntner’s global impact Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal,
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 20:45:00 CEST | Press release
Windsurf launches a GPU cluster in Germany, delivering 50% faster performance and secure access to European enterprises. Data residency ensures enterprise repositories stay within the EU, meeting stringent security requirements. Windsurf already supports 100+ European enterprise customers, highlighting strong demand for AI-powered development tools across EMEA. Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 19:00:00 CEST | Press release
New SDK Integration Simplifies Monetization for Defold Developers Publishing on CrazyGames Ahead of Global Game Jam Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization jou
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 17:00:00 CEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom